R Rodvien, C H Mielke. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Blood Platelets/drug effectsBlood Platelets/physiologyCerebrovascular Disorders/drug therapyFemaleFibrinolytic Agents/therapeutic useHumansIntracranial Embolism and Thrombosis/bloodIschemic Attack, Transient/bloodIschemic Attack, Transient/drug therapyMalePlatelet Adhesiveness/drug effectsPlatelet Aggregation/drug effectsSulfinpyrazone/therapeutic useThromboxanes/physiology
Substances: See more » Fibrinolytic AgentsThromboxanesSulfinpyrazone
Year: 1978 PMID: 675751 DOI: 10.1161/01.str.9.4.403
Source DB: PubMed Journal: Stroke ISSN: 0039-2499 Impact factor: 7.914